Linlu Ma

4.7k total citations · 2 hit papers
26 papers, 1.6k citations indexed

About

Linlu Ma is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Linlu Ma has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Linlu Ma's work include Acute Myeloid Leukemia Research (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Linlu Ma is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Linlu Ma collaborates with scholars based in China and United States. Linlu Ma's co-authors include Xinghuan Wang, Hong Weng, Xian‐Tao Zeng, Zhihua Yang, Di Huang, Fuling Zhou, Nan Zhang, Xiaoyan Liu, Yuxing Liang and Jinxian Wu and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Nutrients.

In The Last Decade

Linlu Ma

22 papers receiving 1.5k citations

Hit Papers

Methodological quality (r... 2020 2026 2022 2024 2020 2023 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Linlu Ma 197 183 169 157 132 26 1.6k
Ferhan Elmalı 187 0.9× 132 0.7× 161 1.0× 142 0.9× 111 0.8× 130 1.3k
Silvia Gianola 221 1.1× 343 1.9× 188 1.1× 92 0.6× 111 0.8× 101 2.1k
Jill Jin 163 0.8× 117 0.6× 123 0.7× 172 1.1× 110 0.8× 154 1.1k
Antônio José Grande 160 0.8× 161 0.9× 173 1.0× 124 0.8× 159 1.2× 115 1.6k
Rasheda Rabbani 246 1.2× 224 1.2× 250 1.5× 145 0.9× 97 0.7× 71 1.5k
Ronald Buyl 183 0.9× 287 1.6× 152 0.9× 152 1.0× 180 1.4× 135 1.9k
Robin High 173 0.9× 299 1.6× 123 0.7× 111 0.7× 73 0.6× 98 1.4k
Jennifer Stone 203 1.0× 209 1.1× 212 1.3× 82 0.5× 72 0.5× 47 1.6k
Patrícia Klarmann Ziegelmann 198 1.0× 256 1.4× 208 1.2× 152 1.0× 183 1.4× 86 1.9k
Shu‐Yuan Liang 168 0.9× 145 0.8× 115 0.7× 297 1.9× 106 0.8× 92 1.3k

Countries citing papers authored by Linlu Ma

Since Specialization
Citations

This map shows the geographic impact of Linlu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlu Ma more than expected).

Fields of papers citing papers by Linlu Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linlu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlu Ma. The network helps show where Linlu Ma may publish in the future.

Co-authorship network of co-authors of Linlu Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Linlu Ma. A scholar is included among the top collaborators of Linlu Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linlu Ma. Linlu Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Nan, Qian Wang, Ping Chen, et al.. (2025). Jab1 promotes immune evasion and progression in acute myeloid leukemia models under oxidative stress. Journal of Clinical Investigation. 135(20).
2.
Liu, Xiaoyan, Xinqi Li, Tingting Huang, et al.. (2025). Critical role of niche S100A8 for acute myeloid leukemia progression and hematopoiesis regeneration. Blood Advances. 9(24). 6575–6589. 1 indexed citations
4.
Tan, Yuxin, Qian Wang, Rong Xu, et al.. (2024). FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia. Cancer Letters. 592. 216933–216933. 12 indexed citations
5.
Shang, Yufeng, Guopeng Chen, Li Liu, et al.. (2024). Clinical and immunological characteristics of high-risk double-hit multiple myeloma. BMC Cancer. 24(1). 1373–1373.
6.
Li, Xinqi, Nan Zhang, Linlu Ma, et al.. (2024). Prevalence trends of anemia impairment in adolescents and young adults with HIV/AIDS. BMC Public Health. 24(1). 1301–1301. 2 indexed citations
8.
Zhang, Nan, Xinqi Li, Linlu Ma, et al.. (2023). Prevalence Trends of Anemia Impairment in Adolescents and Young Adults with HIV/AIDS. Blood. 142(Supplement 1). 5192–5192. 1 indexed citations
9.
Zhang, Nan, Jinxian Wu, Yuxing Liang, et al.. (2023). Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer Journal. 13(1). 82–82. 168 indexed citations breakdown →
11.
Liang, Yuxing, Nan Zhang, Miao Wang, et al.. (2023). Distributions and Trends of the Global Burden of Colorectal Cancer Attributable to Dietary Risk Factors over the Past 30 Years. Nutrients. 16(1). 132–132. 32 indexed citations
12.
Chen, Longfei, Le Yu, Yantong Liu, et al.. (2022). Space-time-regulated imaging analyzer for smart coagulation diagnosis. Cell Reports Medicine. 3(10). 100765–100765. 18 indexed citations
13.
Chen, Ping, Wenyan She, Chao-Chao Yu, et al.. (2022). A novel organic arsenic derivative MZ2 remodels metabolism and triggers mtROS-mediated apoptosis in acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 149(8). 4225–4242. 2 indexed citations
14.
Xiao, Wei, Linlu Ma, Yufeng Shang, et al.. (2022). Cardiac-Related Lesions in Newly Diagnosed Patients With Acute Leukemia: A Chinese Population-Based Real-World Study. Frontiers in Medicine. 9. 844350–844350. 4 indexed citations
15.
Chen, Longfei, Yantong Liu, Linlu Ma, et al.. (2021). Touchable cell biophysics property recognition platforms enable multifunctional blood smart health care. Microsystems & Nanoengineering. 7(1). 103–103. 21 indexed citations
16.
Ma, Linlu, Xinghuan Wang, Zhihua Yang, et al.. (2020). Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?. Military Medical Research. 7(1). 7–7. 1205 indexed citations breakdown →
17.
Zhou, Fuling, Jingfeng Li, Mengxin Lü, et al.. (2020). Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey. EClinicalMedicine. 26. 100510–100510. 14 indexed citations
18.
Wang, Yan‐Bo, Gang Lv, Fenghua Xu, Linlu Ma, & Yong-ming Yao. (2020). Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov. Frontiers in Pharmacology. 10. 1539–1539. 5 indexed citations
19.
Ma, Linlu, Yang Qiu, Yun Chen, et al.. (2019). Clinical Trial Registration and Reporting: Drug Therapy and Prevention of Cardiac-Related Infections. Frontiers in Pharmacology. 10. 757–757. 5 indexed citations
20.
Wang, Chaoyang, Binghui Li, Linlu Ma, et al.. (2019). The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia. Frontiers in Pharmacology. 10. 108–108. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026